Open Access

Clinical presentation and endoscopic features of primary gastric Burkitt lymphoma in childhood, presenting as a protein-losing enteropathy: a case report

  • Jenny Hui Chia Chieng1,
  • John Garrett1,
  • Steven Leslie Ding2 and
  • Michael Sullivan1, 3Email author
Journal of Medical Case Reports20093:7256

https://doi.org/10.4076/1752-1947-3-7256

Received: 31 August 2008

Accepted: 23 January 2009

Published: 9 June 2009

Abstract

Introduction

Burkitt lymphoma and B cell lymphomas in childhood may arise in many atypical locations, which on rare occasions can include gastric mucosa. A case of primary gastric Burkitt lymphoma is described in a child presenting as a protein-losing enteropathy, including the direct monitoring of the disease response by sequential endoscopic biopsy and molecular analysis.

Case presentation

We report a 9-year-old boy who presented with gross oedema, ascites and respiratory distress caused by a protein-losing enteropathy. Initial imaging investigations were non-diagnostic but gastroduodenal endoscopy revealed massive involvement of the gastric mucosa with a primary Burkitt lymphoma. His subsequent clinical progress and disease response were monitored directly by endoscopy and he remains in clinical remission 4 years after initial diagnosis.

Conclusions

This is the first case report of primary Burkitt lymphoma presenting as a protein-losing enteropathy. The clinical course and progress of the patient were monitored by sequential endoscopic biopsy, histology and molecular analysis by fluorescence in situ hybridisation.

Introduction

Protein-losing enteropathy (PLE) has many causes including gastrointestinal lymphoma [13], however, there are no reports of protein-losing enteropathy caused by a primary gastric lymphoma in childhood. Here we report the clinical presentation, endoscopic features and outcome of a child with PLE caused by Burkitt lymphoma of the stomach.

Case presentation

A previously healthy 9-year-old boy with normal growth and development presented with progressive pallor, peripheral oedema and respiratory distress. Examination showed pallor, pitting oedema, and respiratory distress. No lymphadenopathy, jaundice, hepatosplenomegaly or abdominal masses were present, and the remainder of the physical examination was normal.

Investigations showed hypoalbuminaemia; albumin 16 g/L, and total protein 27 g/L, with normal liver and renal function. The urine was normal with no proteinuria or haematuria. Haemoglobin (Hb) was 89 g/L, white blood cell count (WCC) 16.6 × 109/L, but neutrophils and lymphocytes and blood film were normal.

The chest X-ray (CXR) showed consolidation in the right lower lobe and an abdominal ultrasound scan was normal.

At gastroduodenal endoscopy, multiple raised large (2 to 3 cm in diameter) ulcerated tumours of the greater curvature of the gastric body were seen (Figure 1), and numerous smaller tumours were seen in the second and third part of the duodenum but colonoscopy was normal.
Figure 1

Gastric endoscopy. (A, B) Gastric body tumours; multiple large (2 to 3 cm in diameter) raised ulcerated tumours involving the greater curvature of the gastric body and numerous smaller tumours in the second and third part of the duodenum, as far as the gastroscope could reach. (C) Gastric body tumour after 1 week of chemotherapy. (D) Gastric body tumour after 5 months of chemotherapy demonstrating complete resolution of the lymphomatous masses with only residual scaring present.

Computed tomography (CT) of the chest and abdomen showed multiple exophytic lesions in the stomach, several filling defects within the jejunum, and a 5 cm long intussusception in the ileum (Figure 2). Small lymph nodes were seen around the superior mesenteric vessels. Bilateral pleural effusions and atelectasis were seen in the chest but there was no mediastinal lymphadenopathy.
Figure 2

Computed tomography scan of the abdomen at diagnosis. Exophytic masses with multiple filling defects are present in the gastric mucosa.

Gastric biopsies showed a diffuse lymphoid infiltrate (Figure 3A), immunohistochemistry identified a B-cell population and flow cytometry was positive for the B-cell markers CD20, CD10 and CD43 (Figure 3B). Fluorescence in situ hybridisation (FISH) was positive for the C-MYC, t(8:14) translocation of Burkitt lymphoma. The bone marrow aspirate, trephine biopsy and cerebrospinal fluid (CSF) were normal. No Helicobacter pylori infection was detected.
Figure 3

Histology and immunohistochemistry of gastric biopsies. (A) Haematoxylin and eosin stained section of gastric biopsy showing diffuse small blue round cell infiltrate. (B) Immunohistochemistry with CD20 showing gastric infiltrate to be of B-cell lineage.

The histology, immunophenotype and FISH analysis of the biopsies, and the radiological findings were consistent with a primary gastrointestinal Burkitt lymphoma, Stage III, Group B.

Treatment was according to the UKCCSG consensus guideline for Burkitt lymphoma (2003). Induction chemotherapy with cyclophosphamide, vincristine and prednisone (COP) was given together with alkaline hydration and allopurinol, daily albumin infusions, frusemide and omeprazole.

No tumour lysis syndrome occurred, and there was a rapid rise in serum albumin and protein with resolution of clinical signs of protein-losing enteropathy.

Further chemotherapy included two courses of cyclophosphamide, vincristine, prednisone, cytarabine, doxorubicin and methotrexate (COPADAM) followed by two courses of cytarabine and methotrexate (CYM) and double intrathecal chemotherapy of methotrexate and hydrocortisone.

Our patient's clinical course and disease response were monitored by sequential endoscopic biopsy, histology and molecular analysis by FISH. The rapid clinical response was reflected in the rapid histological and molecular resolution of disease. Follow-up endoscopy showed complete resolution of the mucosal tumours with only residual mucosal puckering present. Abdominal CT cans were normal and, once in remission and having completed chemotherapy, the patient's ongoing disease surveillance was by endoscopy and repeat biopsy for FISH analysis. No molecular evidence of residual disease was detected, and he remains in clinical remission with complete resolution of the protein-losing enteropathy and no treatment related sequelae 4 years from initial diagnosis.

Discussion

Lymphoma is a well-known cause of protein-losing enteropathy in adults. However, in most cases, it is caused by either diffuse nodal infiltration obstructing intestinal lymphatics or a primary mucosal lymphoma located more distally in the small intestine [13]. However, primary gastric lymphoma is rare in the paediatric population, and most of these cases have been associated with gastrointestinal symptoms such as pain, dysphagia, bleeding or gastric outlet obstruction [410].

Several cases of primary gastric lymphoma have been described in children in association with concomitant Helicobacter pylori infection. Blecker et al. described a single case of mucosa-associated lymphoid tissue (MALT) lymphoma more commonly found in adults in a 14-year-old girl with a history of H. pylori associated chronic gastritis [11]. More recently, Mezlini et al. described two further cases of MALT lymphomas in children with concomitant H. pylori infection [12]. These children presented with similar clinical features to those seen in adults.

We report the endoscopic findings of primary gastric Burkitt lymphoma in childhood presenting as a protein-losing enteropathy. The diagnosis here was made difficult by the absence of chronic or acute gastrointestinal symptoms and initial imaging studies also did not indicate a likely aetiology. It was only on endoscopy that other more common causes such as primary intestinal lymphangiectasia, inflammatory diseases and infection were excluded. Here, gastroduodenal endoscopy provided an accurate diagnosis and staging, and was the most useful modality in monitoring the response to treatment.

Burkitt and B-cell lymphomas in childhood have an excellent overall prognosis regardless of the location (except for primary central nervous system (CNS) lymphoma), especially when treated with contemporary chemotherapy protocols [13].

Conclusion

Primary Burkett lymphoma of the gastric mucosa is uncommon in childhood. We report a child presenting with a protein-losing enteropathy whose subsequent clinical course was monitored by sequential endoscopic biopsy and molecular analysis by FISH. The clinical outcome for Burkitt lymphoma in childhood is excellent, even when presenting in unusual sites with rare clinical manifestations.

Consent

Written informed consent was obtained from the patient's parent for publication of this case report and any accompanying images, as the child was a minor. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Abbreviations

CNS: 

central nervous system

COP: 

cyclophosphamide, vincristine, prednisone

COPADAM: 

cyclophosphamide, vincristine, prednisone, cytarabine and methotrexate

CSF: 

cerebrospinal fluid

CT: 

computed tomography

CXR: 

chest X-ray

CYM: 

cytarabine and methotrexate

FISH: 

fluorescent in situ hybridisation

Hb: 

haemoglobin

MALT: 

mucosa-associated lymphoid tissue

WCC: 

white cell count.

Declarations

Authors’ Affiliations

(1)
Department of Paediatrics, Christchurch Hospital
(2)
Department of Gastroenterology, Christchurch Hospital
(3)
Children's Cancer Research Group, University of Otago

References

  1. Hatano B, Ohshima K, Tsuchiya T, Yamaguchi T, Kawasaki C, Kikuchi M: Clinicopathological features of gastric B-cell lymphoma: a series of 317 cases. Pathol Int. 2002, 52: 677-682. 10.1046/j.1440-1827.2002.01403.x.View ArticlePubMedGoogle Scholar
  2. Konar A, Brown CB, Hancock BW, Moss S: Protein losing enteropathy as a sole manifestation of Non-Hodgkin's Lymphoma. Postgrad Med J. 1986, 62: 399-400. 10.1136/pgmj.62.727.399.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Silbert AJ, Ireland JD, Uys PJ, Bowie MD: Hodgkin's lymphoma presenting as a protein-losing enteropathy: a case report. S Afr Med J. 1980, 57: 1009-1011.PubMedGoogle Scholar
  4. Bakir T, Gumustekin E, Bozalioglu H, Tezic T, Ozoran Y: Gastric involvement in childhood non-Hodgkin's lymphoma: a case report. Turk J Pediatr. 1991, 33: 43-47.PubMedGoogle Scholar
  5. Harris GJ, Laszewski MJ: Pediatric primary gastric lymphoma. South Med J. 1992, 85: 432-434. 10.1097/00007611-199204000-00024.View ArticlePubMedGoogle Scholar
  6. Martin de Pablos J, Santano Dominguez M, Blanco Yun A, Sanchez Calero J: [A primary gastric Burkitt's lymphoma in a child]. Rev Esp Enferm Dig. 1992, 82: 189-191.PubMedGoogle Scholar
  7. Skinner MA, Plumley DA, Grosfeld JL, Rescorla FJ, West KW, Scherer LR: Gastrointestinal tumors in children: an analysis of 39 cases. Ann Surg Oncol. 1994, 1: 283-289. 10.1007/BF02303566.View ArticlePubMedGoogle Scholar
  8. Ciftci AO, Tanyel FC, Kotiloglu E, Hicsonmez A: Gastric lymphoma causing gastric outlet obstruction. J Pediatr Surg. 1996, 31: 1424-1426. 10.1016/S0022-3468(96)90845-3.View ArticlePubMedGoogle Scholar
  9. Bethel CA, Bhattacharyya N, Hutchinson C, Ruymann F, Cooney DR: Alimentary tract malignancies in children. J Pediatr Surg. 1997, 32: 1004-1008. 10.1016/S0022-3468(97)90387-0.View ArticlePubMedGoogle Scholar
  10. Yadav S, Gupta R, Oak SN, Rathi P, Kulkarni BK, Sawant P: Primary gastric lymphoma in a boy. Indian J Gastroenterol. 1997, 16: 112-113.PubMedGoogle Scholar
  11. Blecker U, McKeithan TW, Hart J, Kirschner BS: Resolution of Helicobacter pylori-associated gastric lymphoproliferative disease in a child. Gastroenterology. 1995, 109: 973-977. 10.1016/0016-5085(95)90408-5.View ArticlePubMedGoogle Scholar
  12. Mezlini A, Kchir N, Chaabouni M, Ben Rejeb A, Ben Ayed F: [Primary gastric MALT lymphoma in children. Report of 2 cases]. Arch Anat Cytol Pathol. 1999, 47: 38-43.PubMedGoogle Scholar
  13. Cairo MS, Sposto R, Perkins SL, Meadows AT, Hoover-Regan ML, Anderson JR, Siegel SE, Lones MA, Tedeschi-Blok N, Kadin ME, Kjeldsberg CR, Wilson JF, Sanger W, Morris E, Krailo MD, Finlay JL: Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience. Br J Haematol. 2003, 120: 660-670. 10.1046/j.1365-2141.2003.04134.x.View ArticlePubMedGoogle Scholar

Copyright

© Chieng et al; licensee Cases Network Ltd. 2009

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.